Marina Biotech Inc., of Bothell, Wash., amended its license agreement with Mirna Therapeutics Inc., of Austin, Texas, related to development and commercialization of microRNA-based therapeutics based on its microRNAs and its SMARTICLES liposomal delivery technology.